Global Mucopolysaccharidosis (MPS) Treatment Market Size, Status and Forecast 2024-2031

Report ID: 918510 | Published Date: Sep 2024 | No. of Page: 109 | Base Year: 2023 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Mucopolysaccharidosis (MPS) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Stem Cell Therapies
        1.2.3 Enzyme Replacement Therapies
    1.3 Market by Application
        1.3.1 Global Mucopolysaccharidosis (MPS) Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Homecare
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Mucopolysaccharidosis (MPS) Treatment Market Perspective (2016-2027)
    2.2 Mucopolysaccharidosis (MPS) Treatment Growth Trends by Regions
        2.2.1 Mucopolysaccharidosis (MPS) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Mucopolysaccharidosis (MPS) Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Mucopolysaccharidosis (MPS) Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Mucopolysaccharidosis (MPS) Treatment Industry Dynamic
        2.3.1 Mucopolysaccharidosis (MPS) Treatment Market Trends
        2.3.2 Mucopolysaccharidosis (MPS) Treatment Market Drivers
        2.3.3 Mucopolysaccharidosis (MPS) Treatment Market Challenges
        2.3.4 Mucopolysaccharidosis (MPS) Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Mucopolysaccharidosis (MPS) Treatment Players by Revenue
        3.1.1 Global Top Mucopolysaccharidosis (MPS) Treatment Players by Revenue (2016-2021)
        3.1.2 Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Mucopolysaccharidosis (MPS) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Mucopolysaccharidosis (MPS) Treatment Revenue
    3.4 Global Mucopolysaccharidosis (MPS) Treatment Market Concentration Ratio
        3.4.1 Global Mucopolysaccharidosis (MPS) Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Mucopolysaccharidosis (MPS) Treatment Revenue in 2020
    3.5 Mucopolysaccharidosis (MPS) Treatment Key Players Head office and Area Served
    3.6 Key Players Mucopolysaccharidosis (MPS) Treatment Product Solution and Service
    3.7 Date of Enter into Mucopolysaccharidosis (MPS) Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Mucopolysaccharidosis (MPS) Treatment Breakdown Data by Type
    4.1 Global Mucopolysaccharidosis (MPS) Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Mucopolysaccharidosis (MPS) Treatment Forecasted Market Size by Type (2022-2027)

5 Mucopolysaccharidosis (MPS) Treatment Breakdown Data by Application
    5.1 Global Mucopolysaccharidosis (MPS) Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Mucopolysaccharidosis (MPS) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Mucopolysaccharidosis (MPS) Treatment Market Size (2016-2027)
    6.2 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Type
        6.2.1 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2021)
        6.2.2 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2022-2027)
        6.2.3 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2027)
    6.3 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Application
        6.3.1 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2021)
        6.3.2 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2022-2027)
        6.3.3 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2027)
    6.4 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Country
        6.4.1 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2016-2021)
        6.4.2 North America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Mucopolysaccharidosis (MPS) Treatment Market Size (2016-2027)
    7.2 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type
        7.2.1 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2027)
    7.3 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application
        7.3.1 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2027)
    7.4 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Country
        7.4.1 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Type
        8.2.1 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Application
        8.3.1 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Region
        8.4.1 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size (2016-2027)
    9.2 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Type
        9.2.1 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2027)
    9.3 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Application
        9.3.1 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2027)
    9.4 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Country
        9.4.1 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type
        10.2.1 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application
        10.3.1 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Country
        10.4.1 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Sanofi
        11.1.1 Sanofi Company Details
        11.1.2 Sanofi Business Overview
        11.1.3 Sanofi Mucopolysaccharidosis (MPS) Treatment Introduction
        11.1.4 Sanofi Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021)
        11.1.5 Sanofi Recent Development
    11.2 Shire (Takeda)
        11.2.1 Shire (Takeda) Company Details
        11.2.2 Shire (Takeda) Business Overview
        11.2.3 Shire (Takeda) Mucopolysaccharidosis (MPS) Treatment Introduction
        11.2.4 Shire (Takeda) Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021)
        11.2.5 Shire (Takeda) Recent Development
    11.3 BioMarin Pharmaceutical
        11.3.1 BioMarin Pharmaceutical Company Details
        11.3.2 BioMarin Pharmaceutical Business Overview
        11.3.3 BioMarin Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Introduction
        11.3.4 BioMarin Pharmaceutical Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021)
        11.3.5 BioMarin Pharmaceutical Recent Development
    11.4 Esteve
        11.4.1 Esteve Company Details
        11.4.2 Esteve Business Overview
        11.4.3 Esteve Mucopolysaccharidosis (MPS) Treatment Introduction
        11.4.4 Esteve Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021)
        11.4.5 Esteve Recent Development
    11.5 REGENXBIO Inc
        11.5.1 REGENXBIO Inc Company Details
        11.5.2 REGENXBIO Inc Business Overview
        11.5.3 REGENXBIO Inc Mucopolysaccharidosis (MPS) Treatment Introduction
        11.5.4 REGENXBIO Inc Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021)
        11.5.5 REGENXBIO Inc Recent Development
    11.6 Sangamo Therapeutics
        11.6.1 Sangamo Therapeutics Company Details
        11.6.2 Sangamo Therapeutics Business Overview
        11.6.3 Sangamo Therapeutics Mucopolysaccharidosis (MPS) Treatment Introduction
        11.6.4 Sangamo Therapeutics Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021)
        11.6.5 Sangamo Therapeutics Recent Development
    11.7 Ultragenyx Pharmaceutical
        11.7.1 Ultragenyx Pharmaceutical Company Details
        11.7.2 Ultragenyx Pharmaceutical Business Overview
        11.7.3 Ultragenyx Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Introduction
        11.7.4 Ultragenyx Pharmaceutical Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021)
        11.7.5 Ultragenyx Pharmaceutical Recent Development
    11.8 Abeona Therapeutics
        11.8.1 Abeona Therapeutics Company Details
        11.8.2 Abeona Therapeutics Business Overview
        11.8.3 Abeona Therapeutics Mucopolysaccharidosis (MPS) Treatment Introduction
        11.8.4 Abeona Therapeutics Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021)
        11.8.5 Abeona Therapeutics Recent Development
    11.9 ArmaGen
        11.9.1 ArmaGen Company Details
        11.9.2 ArmaGen Business Overview
        11.9.3 ArmaGen Mucopolysaccharidosis (MPS) Treatment Introduction
        11.9.4 ArmaGen Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021)
        11.9.5 ArmaGen Recent Development
    11.10 Eloxx Pharmaceuticals
        11.10.1 Eloxx Pharmaceuticals Company Details
        11.10.2 Eloxx Pharmaceuticals Business Overview
        11.10.3 Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Introduction
        11.10.4 Eloxx Pharmaceuticals Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021)
        11.10.5 Eloxx Pharmaceuticals Recent Development
    11.11 Inventiva
        11.11.1 Inventiva Company Details
        11.11.2 Inventiva Business Overview
        11.11.3 Inventiva Mucopolysaccharidosis (MPS) Treatment Introduction
        11.11.4 Inventiva Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021)
        11.11.5 Inventiva Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Mucopolysaccharidosis (MPS) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Stem Cell Therapies
    Table 3. Key Players of Enzyme Replacement Therapies
    Table 4. Global Mucopolysaccharidosis (MPS) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Mucopolysaccharidosis (MPS) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Mucopolysaccharidosis (MPS) Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Mucopolysaccharidosis (MPS) Treatment Market Share by Regions (2016-2021)
    Table 8. Global Mucopolysaccharidosis (MPS) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Mucopolysaccharidosis (MPS) Treatment Market Share by Regions (2022-2027)
    Table 10. Mucopolysaccharidosis (MPS) Treatment Market Trends
    Table 11. Mucopolysaccharidosis (MPS) Treatment Market Drivers
    Table 12. Mucopolysaccharidosis (MPS) Treatment Market Challenges
    Table 13. Mucopolysaccharidosis (MPS) Treatment Market Restraints
    Table 14. Global Mucopolysaccharidosis (MPS) Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Mucopolysaccharidosis (MPS) Treatment Market Share by Players (2016-2021)
    Table 16. Global Top Mucopolysaccharidosis (MPS) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mucopolysaccharidosis (MPS) Treatment as of 2020)
    Table 17. Ranking of Global Top Mucopolysaccharidosis (MPS) Treatment Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Mucopolysaccharidosis (MPS) Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Mucopolysaccharidosis (MPS) Treatment Product Solution and Service
    Table 21. Date of Enter into Mucopolysaccharidosis (MPS) Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Type (2016-2021)
    Table 25. Global Mucopolysaccharidosis (MPS) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Mucopolysaccharidosis (MPS) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Application (2016-2021)
    Table 29. Global Mucopolysaccharidosis (MPS) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Sanofi Company Details
    Table 62. Sanofi Business Overview
    Table 63. Sanofi Mucopolysaccharidosis (MPS) Treatment Product
    Table 64. Sanofi Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) & (US$ Million)
    Table 65. Sanofi Recent Development
    Table 66. Shire (Takeda) Company Details
    Table 67. Shire (Takeda) Business Overview
    Table 68. Shire (Takeda) Mucopolysaccharidosis (MPS) Treatment Product
    Table 69. Shire (Takeda) Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) & (US$ Million)
    Table 70. Shire (Takeda) Recent Development
    Table 71. BioMarin Pharmaceutical Company Details
    Table 72. BioMarin Pharmaceutical Business Overview
    Table 73. BioMarin Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Product
    Table 74. BioMarin Pharmaceutical Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) & (US$ Million)
    Table 75. BioMarin Pharmaceutical Recent Development
    Table 76. Esteve Company Details
    Table 77. Esteve Business Overview
    Table 78. Esteve Mucopolysaccharidosis (MPS) Treatment Product
    Table 79. Esteve Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) & (US$ Million)
    Table 80. Esteve Recent Development
    Table 81. REGENXBIO Inc Company Details
    Table 82. REGENXBIO Inc Business Overview
    Table 83. REGENXBIO Inc Mucopolysaccharidosis (MPS) Treatment Product
    Table 84. REGENXBIO Inc Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) & (US$ Million)
    Table 85. REGENXBIO Inc Recent Development
    Table 86. Sangamo Therapeutics Company Details
    Table 87. Sangamo Therapeutics Business Overview
    Table 88. Sangamo Therapeutics Mucopolysaccharidosis (MPS) Treatment Product
    Table 89. Sangamo Therapeutics Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) & (US$ Million)
    Table 90. Sangamo Therapeutics Recent Development
    Table 91. Ultragenyx Pharmaceutical Company Details
    Table 92. Ultragenyx Pharmaceutical Business Overview
    Table 93. Ultragenyx Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Product
    Table 94. Ultragenyx Pharmaceutical Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) & (US$ Million)
    Table 95. Ultragenyx Pharmaceutical Recent Development
    Table 96. Abeona Therapeutics Company Details
    Table 97. Abeona Therapeutics Business Overview
    Table 98. Abeona Therapeutics Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) & (US$ Million)
    Table 99. Abeona Therapeutics Recent Development
    Table 100. ArmaGen Company Details
    Table 101. ArmaGen Business Overview
    Table 102. ArmaGen Mucopolysaccharidosis (MPS) Treatment Product
    Table 103. ArmaGen Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) & (US$ Million)
    Table 104. ArmaGen Recent Development
    Table 105. Eloxx Pharmaceuticals Company Details
    Table 106. Eloxx Pharmaceuticals Business Overview
    Table 107. Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Product
    Table 108. Eloxx Pharmaceuticals Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) & (US$ Million)
    Table 109. Eloxx Pharmaceuticals Recent Development
    Table 110. Inventiva Company Details
    Table 111. Inventiva Business Overview
    Table 112. Inventiva Mucopolysaccharidosis (MPS) Treatment Product
    Table 113. Inventiva Revenue in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021) & (US$ Million)
    Table 114. Inventiva Recent Development
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Mucopolysaccharidosis (MPS) Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Stem Cell Therapies Features
    Figure 3. Enzyme Replacement Therapies Features
    Figure 4. Global Mucopolysaccharidosis (MPS) Treatment Market Share by Application: 2020 VS 2027
    Figure 5. Hospitals Case Studies
    Figure 6. Clinics Case Studies
    Figure 7. Homecare Case Studies
    Figure 8. Mucopolysaccharidosis (MPS) Treatment Report Years Considered
    Figure 9. Global Mucopolysaccharidosis (MPS) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Mucopolysaccharidosis (MPS) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Mucopolysaccharidosis (MPS) Treatment Market Share by Regions: 2020 VS 2027
    Figure 12. Global Mucopolysaccharidosis (MPS) Treatment Market Share by Regions (2022-2027)
    Figure 13. Global Mucopolysaccharidosis (MPS) Treatment Market Share by Players in 2020
    Figure 14. Global Top Mucopolysaccharidosis (MPS) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mucopolysaccharidosis (MPS) Treatment as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Mucopolysaccharidosis (MPS) Treatment Revenue in 2020
    Figure 16. Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Type (2016-2021)
    Figure 17. Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Type (2022-2027)
    Figure 18. North America Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Mucopolysaccharidosis (MPS) Treatment Market Share by Type (2016-2027)
    Figure 20. North America Mucopolysaccharidosis (MPS) Treatment Market Share by Application (2016-2027)
    Figure 21. North America Mucopolysaccharidosis (MPS) Treatment Market Share by Country (2016-2027)
    Figure 22. United States Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Mucopolysaccharidosis (MPS) Treatment Market Share by Type (2016-2027)
    Figure 26. Europe Mucopolysaccharidosis (MPS) Treatment Market Share by Application (2016-2027)
    Figure 27. Europe Mucopolysaccharidosis (MPS) Treatment Market Share by Country (2016-2027)
    Figure 28. Germany Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Market Share by Region (2016-2027)
    Figure 38. China Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Mucopolysaccharidosis (MPS) Treatment Market Share by Type (2016-2027)
    Figure 46. Latin America Mucopolysaccharidosis (MPS) Treatment Market Share by Application (2016-2027)
    Figure 47. Latin America Mucopolysaccharidosis (MPS) Treatment Market Share by Country (2016-2027)
    Figure 48. Mexico Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Share by Country (2016-2027)
    Figure 54. Turkey Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Mucopolysaccharidosis (MPS) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Sanofi Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021)
    Figure 58. Shire (Takeda) Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021)
    Figure 59. BioMarin Pharmaceutical Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021)
    Figure 60. Esteve Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021)
    Figure 61. REGENXBIO Inc Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021)
    Figure 62. Sangamo Therapeutics Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021)
    Figure 63. Ultragenyx Pharmaceutical Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021)
    Figure 64. Abeona Therapeutics Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021)
    Figure 65. ArmaGen Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021)
    Figure 66. Eloxx Pharmaceuticals Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021)
    Figure 67. Inventiva Revenue Growth Rate in Mucopolysaccharidosis (MPS) Treatment Business (2016-2021)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
Shire (Takeda)
BioMarin Pharmaceutical
Esteve
REGENXBIO Inc
Sangamo Therapeutics
Ultragenyx Pharmaceutical
Abeona Therapeutics
ArmaGen
Eloxx Pharmaceuticals
Inventiva
Frequently Asked Questions
Mucopolysaccharidosis (MPS) Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Mucopolysaccharidosis (MPS) Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Mucopolysaccharidosis (MPS) Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports